Managing atrial fibrillation in the elderly: critical appraisal of dronedarone

References

• RileyABManningWJAtrial fibrillation: an epidemic in the elderlyExpert Rev Cardiovasc Ther201191081109021878052
   PubMedGoogle Scholar
• StewartSHartCLHoleDJMcMurrayJJPopulation prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley studyHeart20018651652111602543
   PubMed Web of Science ®Google Scholar
• GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA20012852370237511343485
   PubMed Web of Science ®Google Scholar
• CairnsJAConnollySMcMurtrySStephensonMTalajicMCCS Atrial Fibrillation Guidelines CommitteeCanadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutterCan J Cardiol201127749021329865
   PubMed Web of Science ®Google Scholar
• GattellariMGoumasCAitkenRWorthingtonJMOutcomes for patients with ischaemic stroke and atrial fibrillation: The PRISM Study (A Program of Research Informing Stroke Management)Cerebrovasc Dis20113237038221921601
   PubMed Web of Science ®Google Scholar
• WolfPAAbbottRDKannelWBAtrial fibrillation as an independent risk factor for stroke: the Framingham studyStroke1991229839881866765
   PubMed Web of Science ®Google Scholar
• RogerVLGoASLloyd-JonesDMAmerican Heart Association, Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2011 update: a report from the American Heart AssociationCirculation201112e18e20921160056
   PubMedGoogle Scholar
• PicciniJPWallaceTWPatelMRBeckerRCStroke prevention in atrial fibrillationCardiovasc Drugs Ther201125656157021927837
   PubMed Web of Science ®Google Scholar
• Le HeuzeyJYMarijonEOtmaniATreatment of atrial fibrillation in heart failureTherapie200964115119 French19664405
   PubMed Web of Science ®Google Scholar
• CorleySDEpsteinAEDiMarcoJPAFFIRM InvestigatorsRelationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) studyCirculation20041091509151315007003
   PubMed Web of Science ®Google Scholar
• HohnloserSHCrijnsHJvanEMEffect of dronedarone on cardiovascular events in atrial fibrillationN Engl J Med200936066867819213680
   PubMed Web of Science ®Google Scholar
• DeneerVHvan HemelNMIs antiarrhythmic treatment in the elderly different? A review of the specific changesDrugs Aging20112861763321812498
   PubMed Web of Science ®Google Scholar
• HuangCCSandroniPSlettenDMWeigandSDLowPAEffect of age on adrenergic and vagal baroreflex sensitivity in normal subjectsMuscle Nerve20073663764217654557
   PubMed Web of Science ®Google Scholar
• BenderAEffect of age on intestinal absorption: implications for drug absorption in the elderlyJ Am Geriatr Soc196816133113395698660
   PubMed Web of Science ®Google Scholar
• DorianPClinical pharmacology of dronedarone: implications for the therapy of atrial fibrillationJ Cardiovasc Pharmacol Ther2010154 Suppl15S18S20472816
   PubMed Web of Science ®Google Scholar
• RoweJWAndresRTobinJDNorrisAHShockNWThe effect of age on creatinine clearance in men: a cross-sectional and longitudinal studyJ Gerontol1976311551631249404
   PubMedGoogle Scholar
• SwenJJWiltingIde GoedeALPharmacogenetics: from bench to byteClin Pharmacol Ther20088378178718253145
   PubMed Web of Science ®Google Scholar
• VogelFModern problems of human geneticsInn Med Kinderheilkd19591252125 German
   Google Scholar
• AlvingASCarsonPEFlanaganCLIckesCEEnzymatic deficiency in primaquine sensitive erythrocytesScience195612448448513360274
   PubMed Web of Science ®Google Scholar
• SeripaDPilottoAPanzaFMateraMGPilottoAPharmacogenetics of cytochrome P450 (CYP) in the elderlyAgeing Res Rev2010945747420601196
   PubMed Web of Science ®Google Scholar
• Ingelman-SundbergMPharmacogenomic biomarkers for prediction of severe adverse drug reactionsN Engl J Med200835863763918256400
   PubMed Web of Science ®Google Scholar
• KawabataMHiraoKHachiyaHRole of oral amiodarone in patients with atrial fibrillation and congestive heart failureJ Cardiol20115810811521831597
   PubMed Web of Science ®Google Scholar
• van ErvenLSchalijMJAmiodarone: an effective antiarrhythmic drug with unusual side effectsHeart2010961593160020837671
   PubMed Web of Science ®Google Scholar
• ConnollySJEvidence-based analysis of amiodarone efficacy and safetyCirculation19991002025203410556230
   PubMed Web of Science ®Google Scholar
• VorperianVRHavighurstTCMillerSJanuaryCTAdverse effects of low dose amiodarone: a meta-analysisJ Am Coll Cardiol1997307917989283542
   PubMed Web of Science ®Google Scholar
• CammAJKirchhofPLipGYEuropean Heart Rhythm Association, European Association for Cardio-Thoracic SurgeryGuidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Europace2010121360142020876603
   PubMed Web of Science ®Google Scholar
• DavyJMHeroldMHoglundCERATO Study InvestigatorsDronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) studyAm Heart J2008156527.e1e918760136
   PubMed Web of Science ®Google Scholar
• BongardVMarcDPhilippeVJean-LouisMMaryseLMIncidence rate of adverse drug reactions during long-term follow-up of patients newly treated with amiodaroneAm J Ther20061331531916858166
   PubMedGoogle Scholar
• WolkoveNBaltzanMAmiodarone pulmonary toxicityCan Respir J200916434819399307
   PubMed Web of Science ®Google Scholar
• SchwaiblmairMBerghausTHaeckelTWagnerTvon ScheidtWAmiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effectClin Res Cardiol20109969370020623129
   PubMed Web of Science ®Google Scholar
• JessurunGABoersmaWGCrijnsHJAmiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatmentDrug Saf1998183393449589845
   PubMed Web of Science ®Google Scholar
• PolkeyMIWilsonPOReesPJAmiodarone pneumonitis: no safe doseRespir Med1995892332357746919
   PubMed Web of Science ®Google Scholar
• TsangWHouldenRLAmiodarone-induced thyrotoxicosis: a reviewCan J Cardiol20092542142419584973
   PubMed Web of Science ®Google Scholar
• ChiovatoLMartinoETonaccheraMStudies on the in vitro cytotoxic effects of amiodaroneEndocrinology1994134227722828156930
   PubMed Web of Science ®Google Scholar
• CardenasGACabralJMLeslieCAAmiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategiesCleve Clin J Med20037062463112882384
   PubMed Web of Science ®Google Scholar
• MantyjarviMTuppurainenKIkaheimoKOcular side effects of amiodaroneSurv Ophthalmol1998423603669493278
   PubMed Web of Science ®Google Scholar
• RajaKThungSNFielMIChangCDrug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone useSemin Liver Dis20092942342819826976
   PubMed Web of Science ®Google Scholar
• BabatinMLeeSSPollakPTAmiodarone hepatotoxicityCurr Vasc Pharmacol2008622823618673162
   PubMed Web of Science ®Google Scholar
• LlanosLMoreuRPeiróAMCausality assessment of liver injury after chronic oral amiodarone intakePharmacoepidemiol Drug Saf20091829130019165760
   PubMed Web of Science ®Google Scholar
• GiannattasioFSalvioAVarrialeMThree cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicityAnn Ital Med Int200217180184 Italian12402666
   PubMedGoogle Scholar
• JamesPRHardmanSMAcute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapyHeart1997775835849227310
   PubMed Web of Science ®Google Scholar
• KumLCChanWWHuiHHPrevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunctionClin Cardiol20062929529916881537
   PubMed Web of Science ®Google Scholar
• StravitzRTSanyalAJDrug-induced steatohepatitisClin Liver Dis2003743545112879993
   PubMedGoogle Scholar
• PuliSRFraleyMAPuliVKupermanABAlpertMAHepatic cirrhosis caused by low-dose oral amiodarone therapyAm J Med Sci200533025726116284489
   PubMed Web of Science ®Google Scholar
• HillemanDMillerMAParkerRDoeringPPieperJAOptimal management of amiodarone therapy: efficacy and side effectsPharmacotherapy1998186 Pt 2138S145S9855346
   PubMed Web of Science ®Google Scholar
• Torp-PedersenCCrijnsHJGaudinCPageRLConnollySJHohnloserSHATHENA InvestigatorsImpact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA studyEuropace2011131118112621576129
   PubMed Web of Science ®Google Scholar
• GuiraudouPPucheuSCGayraudRInvolvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heartEur J Pharmacol200449611912715288583
   PubMed Web of Science ®Google Scholar
• XieCYangSZhongDDaiXChenXSimultaneous determination of dronedarone and its active metabolite debutyldronedarone in human plasma by liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic studyJ Chromatogr B Analyt Technol Biomed Life Sci201187930713075
   Web of Science ®Google Scholar
• PamukcuBLipGYDronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practiceExpert Opin Pharmacother20111213114021126199
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationHighlights of prescribing information Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022425lbl.pdfAccessed October 14, 2011
   Google Scholar
• European Medicines AgencyMultaq; Annex I Summary of product characteristics Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001043/WC500044534.pdfAccessed October 14, 2011
   Google Scholar
• DamyTPoussetFCaplainHPharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjectsFundam Clin Pharmacol20041811312314748763
   PubMed Web of Science ®Google Scholar
• TschuppertYBuclinTRothuizenLEEffect of dronedarone on renal function in healthy subjectsBr J Clin Pharmacol20076478579117662087
   PubMed Web of Science ®Google Scholar
• ZarebaKMDronedarone: a new antiarrhythmic agentDrugs Today (Barc)200642758616541184
   PubMed Web of Science ®Google Scholar
• SchweizerPABeckerRKatusHAThomasDDronedarone: current evidence for its safety and efficacy in the management of atrial fibrillationDrug Des Devel Ther201152739
   PubMed Web of Science ®Google Scholar
• RoseiEASalvettiMDronedarone: an emerging therapy for atrial fibrillationTher Adv Cardiovasc Dis2010415516420418270
   PubMedGoogle Scholar
• PatelCYanGXKoweyPRDronedaroneCirculation200912063664419687370
   PubMed Web of Science ®Google Scholar
• Le HeuzeyJYDe FerrariGMRadzikDSantiniMZhuJDavyJMA short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS studyJ Cardiovasc Electrophysiol20102159760520384650
   PubMed Web of Science ®Google Scholar
• TouboulPBrugadaJCapucciACrijnsHJEdvardssonNHohnloserSHDronedarone for prevention of atrial fibrillation: a dose-ranging studyEur Heart J2003241481148712919771
   PubMed Web of Science ®Google Scholar
• SinghBNConnollySJCrijnsHJDronedarone for maintenance of sinus rhythm in atrial fibrillation or flutterN Engl J Med200735798799917804843
   PubMed Web of Science ®Google Scholar
• FreudenbergerRSWilsonACKostisJBAFFIRM Investigators CommitteesComparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunctionAm J Cardiol200710024725217631079
   PubMed Web of Science ®Google Scholar
• ConnollySJCrijnsHJTorp-PedersenCATHENA InvestigatorsAnalysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutterCirculation20091201174118019752319
   PubMed Web of Science ®Google Scholar
• KoberLTorp-PedersenCMcMurrayJJIncreased mortality after dronedarone therapy for severe heart failureN Engl J Med2008358678687
   Web of Science ®Google Scholar
• NaccarelliGVWolbretteDLKhanMOld and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trialsAm J Cardiol20039115D26D
   PubMed Web of Science ®Google Scholar
• DagresNSommerPAnastasiou-NanaMHindricksGTreating arrhythmias: an expert opinionExpert Opin Pharmacother2011121359136721352091
   PubMed Web of Science ®Google Scholar
• CookGESasichLDSukkariSRAtrial fibrillation DIONYSOS study comparing dronedarone with amiodaroneBMJ2010340c28520085974
   PubMed Web of Science ®Google Scholar
• PicciniJPHasselbladVPetersonEDWashamJBCaliffRMKongDFComparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillationJ Am Coll Cardiol2009541089109519744618
   PubMed Web of Science ®Google Scholar